Nucleic acid encoding mouse galanin receptor (GALR2)
US6337206B1 · kind B1 · utility
1Cited by
2References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 18, 1997 |
| Grant date | Jan 8, 2002 |
| Priority date | — |
| Expiry date | Dec 18, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A new galanin receptor, GALR2, is described. Also provided are nucleic acids encoding same and various assays to identify ligands particular to said receptor. Ligands so identified are useful for the treatment of obesity, treatment of pain, and treatment of cognitive disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.